Literature DB >> 1624082

A case of jejunal gastrinoma diagnosed by percutaneous transhepatic portal venous sampling.

H Nishiwaki1, Y Kawazoe, T Yamashita, K Satake, M Sowa.   

Abstract

A 63-year-old male was admitted to our department for further examination of hypergastrinemia. Secretin provocation test and calcium infusion test suggested Zollinger-Ellison syndrome and percutaneous transhepatic portal venous sampling (PTPVS) demonstrated gastrinoma in the jejunum, although CT, ultrasonography and angiography could not accurately detect the location of the gastrinoma. Laparotomy findings showed a solid tumor 1.5 cm in diameter in the jejunal mesentery 5 cm distal to the ligament of Treitz, and primary gastrinoma was confirmed in the submucosa of the jejunum immediately adjacent to this tumor. An immunohistochemical study using the PAP method revealed gastrin secreting cells in the tumor. In addition to this case of jejunal gastrinoma, a review of literature in Japan and other countries was presented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624082     DOI: 10.1007/bf02777761

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  12 in total

1.  Somatostatin analogue (SMS 201-995) in patients with gastrinomas.

Authors:  A I Vinik; S Tsai; A R Moattari; P Cheung
Journal:  Surgery       Date:  1988-11       Impact factor: 3.982

2.  Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction.

Authors:  J V Glowniak; B Shapiro; A I Vinik; B Glaser; N W Thompson; K J Cho
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

3.  Secretin injection test in the diagnosis of gastrinoma.

Authors:  J E McGuigan; M M Wolfe
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

4.  Curative resection of multiple gastrinomas aided by selective arterial secretin injection test and intraoperative secretin test.

Authors:  M Imamura; K Takahashi; Y Isobe; Y Hattori; K Satomura; T Tobe
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

5.  Zollinger-Ellison syndrome. Cure by surgical resection of a jejunal gastrinoma containing growth hormone releasing factor.

Authors:  D A Antonioli; Y Dayal; A M Dvorak; P A Banks
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

6.  Malignant Zollinger-Ellison syndrome. Stabilization of liver metastasis after gastrectomy with resection of primary tumor.

Authors:  H Katoh; T Yabana; A Yachi; T Tanabe
Journal:  Am Surg       Date:  1990-06       Impact factor: 0.688

7.  Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; J L Doppman; M J Collen; J W Harmon; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

8.  Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases.

Authors:  A Roche; A Raisonnier; M C Gillon-Savouret
Journal:  Radiology       Date:  1982-12       Impact factor: 11.105

9.  The gastrinoma triangle: operative implications.

Authors:  B E Stabile; D J Morrow; E Passaro
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

10.  Gastrinoma: the predictive value of preoperative localization.

Authors:  S R Wise; J Johnson; J Sparks; L C Carey; E C Ellison
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

View more
  2 in total

1.  Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets.

Authors:  Xavier Chopin-Laly; Thomas Walter; Valérie Hervieu; Gilles Poncet; Mustapha Adham; Aymeric Guibal; Jean-Alain Chayvialle; Catherine Lombard-Bohas; Jean-Yves Scoazec
Journal:  Virchows Arch       Date:  2013-04-12       Impact factor: 4.064

Review 2.  Primary jejunal gastrinoma: a case report and review of the literature.

Authors:  Kevin A Wang; Yenn-Hwei Chou; Shu-Han Huang; Tong-Jong Chen
Journal:  World J Surg Oncol       Date:  2015-11-06       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.